← brief for 2026-09-27 · Slowing decline

Rituximab for relapsing nephrotic syndrome in adults: closing the evidence gap

Article No results yet Peer reviewed

Key takeaways

This is a review of studies on a drug called rituximab. It looks at how well the drug works for a kidney condition. There are no new results in this piece. It summarizes what is already known about the drug.

Who did this work

Karol Graňák (Martin University) · Lisa C. Willcocks (Cambridge University Hospitals NHS Foundation Trust)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-09-26
https://doi.org/10.1093/ckj/sfag338